Development of Hit Compounds, for the Treatment of Glioblastoma
Listen to Dr. Aleksandra Dukic, of Institute for Cancer Research, Oslo University Hospital, talk on the use of Incucyte® Live-Cell Analysis, in the development of hit compounds, for the treatment of glioblastoma.
She works on developing a novel and effective treatment, for patients with glioblastoma. Looking for hits to provide better efficacy, Aleksandra has two Incucyte®s. They were chosen as they provided easy, fast high throughput and good reproducibility, for in vivo proof of concept studies. The Incucyte®s take good quality images at the desired time points, for cell-based screening of hit compounds.
Aleksandra says she “really can’t imagine research without an Incucyte”.
#cellanalysis #livecellanalysis #celltherapy #assays #cellculture #livecellimaging #cellbiology